Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viridian Therapeutics, Inc.

15.88
+0.21001.34%
Post-market: 15.930.0500+0.31%19:27 EDT
Volume:708.75K
Turnover:11.18M
Market Cap:1.30B
PE:-4.77
High:15.93
Open:15.22
Low:15.18
Close:15.67
Loading ...
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 18, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Sep 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Sep 12, 2024

Major Issues Report

Form 8-K - Current report